Back

Outcomes of urine sodium guided diuresis in acute heart failure: a preliminary analysis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Diuretic treatment and decongestion Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Ms Chelfi Zhi Fei Chua

Sarawak Heart Center, Kuching (Malaysia)

5 More presentations in this session

Presentation thumbnail
Clinical characteristics and predictors of successful decongestion in patients with acute heart failure: data from the nationwide BRING-UP3 HF study
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Different loop diuretic dosing and administration in acute Heart Failure (DIUR-AHF): effects on congestion renal function and outcome
Associate Professor A. Palazzuoli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Factors associated with a higher diuretic response in acute heart failure (AHF): a post-hoc analysis of the CLOROTIC trial
Doctor J. Morales Rull (Lleida, ES)
Abstract Slides Video
Presentation thumbnail
Impact of initial furosemide dosing on hospitalization and 1-year mortality in acute heart failure
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
The role of acetazolamide in enhancing diuresis in acute decompensated heart failure: insights from a real-world retrospective cohort study
Mrs A. Freitas (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Diuretic treatment and decongestion

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Early response to diuretics and prediction of outcomes in ambulatory worsening heart failure: natriuresis vs. diuresis
thumbnail
Congress Presentation
Diuretic treatment in acute heart failure with volume overload guided by serial spot urine sodium assessment
thumbnail
Congress Presentation
Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo-HF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources